Ludger Grosse-Hovest

Person

Tubingen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
RANKL-specific agent for treating metastatic disease
- Patent number 12,048,744
- Issue date Jul 30, 2024
- Probiocon GmbH
- Helmut Salih
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RANKL-specific agent for treating metastatic disease
- Patent number 10,806,786
- Issue date Oct 20, 2020
- Probiocon GmbH
- Helmut Salih
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant bispecific antibody binding to CD20 and CD95
- Patent number 10,590,202
- Issue date Mar 17, 2020
- Baliopharm AG
- Andreas Herrmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody molecule
- Patent number 9,718,893
- Issue date Aug 1, 2017
- Synimmune GmbH
- Gundram Jung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using bi-specific antibodies for treating B-cell-mediate...
- Patent number 9,624,310
- Issue date Apr 18, 2017
- Gundram Jung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-FLT3 antibodies
- Patent number 9,023,996
- Issue date May 5, 2015
- Synimmune GmbH
- Ludger Grosse-Hovest
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE
- Publication number 20210128722
- Publication date May 6, 2021
- Probiocon GmbH
- Helmut SALIH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT ANTIBODY MOLECULE AND ITS USE FOR TARGET CELL RESTRICTE...
- Publication number 20180208657
- Publication date Jul 26, 2018
- JULIUS-MAXIMILIANS-UNIVERSITÄT WURZBURG
- Gundram JUNG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODY MOLECULE
- Publication number 20180057608
- Publication date Mar 1, 2018
- SYNIMMUNE GMBH
- Gundram Jung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE
- Publication number 20170319687
- Publication date Nov 9, 2017
- Probiocon GmbH
- Helmut SALIH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT BISPECIFIC ANTIBODY BINDING TO CD20 AND CD95
- Publication number 20150274833
- Publication date Oct 1, 2015
- BALIOPHARM AG
- Andreas Herrmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY MOLECULE
- Publication number 20150119555
- Publication date Apr 30, 2015
- SYNIMMUNE GMBH
- Gundram Jung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BI-SPECIFIC ANTIBODIES FOR MEDICAL USE
- Publication number 20140314764
- Publication date Oct 23, 2014
- Gundram Jung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FLT3 ANTIBODIES AND METHODS OF USING THE SAME
- Publication number 20120328612
- Publication date Dec 27, 2012
- Ludger Grosse-Hovest
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ludger Grosse-Hovest

Person

Patents Grantslast 30 patents

RANKL-specific agent for treating metastatic disease

RANKL-specific agent for treating metastatic disease

Recombinant bispecific antibody binding to CD20 and CD95

Bispecific antibody molecule

Methods of using bi-specific antibodies for treating B-cell-mediate...

Anti-FLT3 antibodies

Patents Applicationslast 30 patents

RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE

RECOMBINANT ANTIBODY MOLECULE AND ITS USE FOR TARGET CELL RESTRICTE...

BISPECIFIC ANTIBODY MOLECULE

RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE

RECOMBINANT BISPECIFIC ANTIBODY BINDING TO CD20 AND CD95

BISPECIFIC ANTIBODY MOLECULE

BI-SPECIFIC ANTIBODIES FOR MEDICAL USE

ANTI-FLT3 ANTIBODIES AND METHODS OF USING THE SAME